AU614668B2 - 3-(aminopropyl)methyl phosphinic acid as a therapeutic agent and intermediates in its synthesis - Google Patents

3-(aminopropyl)methyl phosphinic acid as a therapeutic agent and intermediates in its synthesis Download PDF

Info

Publication number
AU614668B2
AU614668B2 AU42043/89A AU4204389A AU614668B2 AU 614668 B2 AU614668 B2 AU 614668B2 AU 42043/89 A AU42043/89 A AU 42043/89A AU 4204389 A AU4204389 A AU 4204389A AU 614668 B2 AU614668 B2 AU 614668B2
Authority
AU
Australia
Prior art keywords
international
document
application
date
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU42043/89A
Other languages
English (en)
Other versions
AU4204389A (en
Inventor
Judith Mary Hills
William Howson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of AU4204389A publication Critical patent/AU4204389A/en
Application granted granted Critical
Publication of AU614668B2 publication Critical patent/AU614668B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5537—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom the heteroring containing the structure -C(=O)-N-C(=O)- (both carbon atoms belong to the heteroring)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU42043/89A 1988-08-26 1989-08-23 3-(aminopropyl)methyl phosphinic acid as a therapeutic agent and intermediates in its synthesis Ceased AU614668B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8820266 1988-08-26
GB888820266A GB8820266D0 (en) 1988-08-26 1988-08-26 Compounds

Publications (2)

Publication Number Publication Date
AU4204389A AU4204389A (en) 1990-03-23
AU614668B2 true AU614668B2 (en) 1991-09-05

Family

ID=10642740

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42043/89A Ceased AU614668B2 (en) 1988-08-26 1989-08-23 3-(aminopropyl)methyl phosphinic acid as a therapeutic agent and intermediates in its synthesis

Country Status (13)

Country Link
EP (1) EP0356128B1 (en:Method)
JP (1) JPH03502101A (en:Method)
AT (1) ATE77747T1 (en:Method)
AU (1) AU614668B2 (en:Method)
DE (1) DE68901961T2 (en:Method)
DK (1) DK101990D0 (en:Method)
ES (1) ES2043025T3 (en:Method)
GB (1) GB8820266D0 (en:Method)
GR (1) GR3005094T3 (en:Method)
IE (1) IE892738L (en:Method)
PT (1) PT91525B (en:Method)
WO (1) WO1990001936A1 (en:Method)
ZA (1) ZA896504B (en:Method)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457095A (en) * 1984-10-12 1995-10-10 Ciba-Geigy Corporation Substituted propane-phosponous acid compounds
US5243062A (en) * 1984-10-12 1993-09-07 Ciba-Geigy Corporation Substituted propane-phosphonous acid compounds
GB8728483D0 (en) * 1987-12-04 1988-01-13 Ciba Geigy Ag Chemical compounds
US5190933A (en) * 1987-12-04 1993-03-02 Ciba-Geigy Corporation Substituted propane-phosphinic acid compounds
US5300679A (en) * 1987-12-04 1994-04-05 Ciba-Geigy Corporation Substituted propane-phosphinic acid compounds
US5567840A (en) * 1989-05-13 1996-10-22 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
US5281747A (en) * 1989-05-13 1994-01-25 Ciba-Geigy Corporation Substituted aminoalkylphosphinic acids
GB8911017D0 (en) * 1989-05-13 1989-06-28 Ciba Geigy Ag Substituted aminoalkylphosphinic acids
US5190934A (en) * 1989-06-03 1993-03-02 Ciba-Geigy Corporation P-subsituted propane-phosphinic acid compounds
GB8912814D0 (en) * 1989-06-03 1989-07-19 Ciba Geigy Ag P-substituted propane-phospinic acid compounds
IL114631A (en) * 1990-06-22 1998-12-06 Novartis Ag Anti-epileptic compositions containing gabab- antagonistic compounds
EP0543780A3 (en) * 1991-11-21 1993-09-01 Ciba-Geigy Ag Novel aminoalkanephosphinic acids and their salts
AU662404B2 (en) * 1992-05-08 1995-08-31 Novartis Ag Novel N-aralkyl- and N-heteroaralkyl-aminoalkanephosphinic acids
GB9308430D0 (en) * 1993-04-23 1993-06-09 Glaxo Group Ltd Medicaments
SE9603408D0 (sv) * 1996-09-18 1996-09-18 Astra Ab Medical use
SE9904507D0 (sv) 1999-12-09 1999-12-09 Astra Ab New compounds
SE9904508D0 (sv) 1999-12-09 1999-12-09 Astra Ab New compounds
US7319095B2 (en) 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
AR033779A1 (es) 2001-06-08 2004-01-07 Astrazeneca Ab Compuestos utiles en la enfermedad de reflujo
GB0327186D0 (en) * 2003-11-21 2003-12-24 Novartis Ag Organic compounds
DK1691811T3 (da) 2003-12-11 2014-10-20 Sunovion Pharmaceuticals Inc Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression
SE0401653D0 (sv) 2004-06-24 2004-06-24 Astrazeneca Ab New compounds
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP2275096A3 (en) 2005-08-26 2011-07-13 Braincells, Inc. Neurogenesis via modulation of the muscarinic receptors
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
JP2009513672A (ja) 2005-10-31 2009-04-02 ブレインセルス，インコーポレイティド 神経発生のｇａｂａ受容体媒介調節
WO2007073298A1 (en) 2005-12-23 2007-06-28 Astrazeneca Ab Imidazole derivatives for the treatment of gastrointestinal disorders
JP2009521430A (ja) 2005-12-23 2009-06-04 アストラゼネカ・アクチエボラーグ Ｇａｂａ−ｂ受容体モジュレーター
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
CA2651862A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2011113904A1 (en) 2010-03-17 2011-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration
WO2012050907A2 (en) 2010-09-28 2012-04-19 The Regents Of The University Of California Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2032712C3 (de) * 1970-07-02 1978-10-19 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von w-Amino-alkanphosphonsäure bzw.- phosphinsäurederivaten
GB8425872D0 (en) * 1984-10-12 1984-11-21 Ciba Geigy Ag Chemical compounds

Also Published As

Publication number Publication date
JPH03502101A (ja) 1991-05-16
WO1990001936A1 (en) 1990-03-08
ES2043025T3 (es) 1993-12-16
DE68901961D1 (en) 1992-08-06
DE68901961T2 (de) 1992-12-24
PT91525B (pt) 1995-05-04
ATE77747T1 (de) 1992-07-15
GR3005094T3 (en:Method) 1993-05-24
ZA896504B (en) 1992-07-29
PT91525A (pt) 1990-03-08
GB8820266D0 (en) 1988-09-28
EP0356128B1 (en) 1992-07-01
IE892738L (en) 1990-02-26
EP0356128A3 (en) 1990-06-13
DK101990A (da) 1990-04-25
AU4204389A (en) 1990-03-23
DK101990D0 (da) 1990-04-25
EP0356128A2 (en) 1990-02-28

Similar Documents

Publication Publication Date Title
AU614668B2 (en) 3-(aminopropyl)methyl phosphinic acid as a therapeutic agent and intermediates in its synthesis
DE69534975T2 (de) Verwendung von noribogain derivaten zur behandlung von chemischer abhängigkeit bei säugern
KR100197454B1 (ko) 디아자비시클릭 뉴로키닌 길항제
US5885548A (en) Multiply substituted DTPA derivatives and their metal complexes, and their metal complexes, pharmaceutical agents that contain these complexes, their use in diagnosis and therapy, as well as process for the production of pharmaceutical agents
JP3838657B2 (ja) 薬学的組成物
EP0130934A1 (de) Neue Komplexbildner, Komplexe und Komplexsalze
ATE186548T1 (de) Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
JPH06510531A (ja) カルシウム受容体活性化分子
CA2120763A1 (en) Dendrimeric polychelants
EP0910567A1 (en) Tricyclic ibogaine analogs, their preparation and their use in treating substance abuse
JPH03163083A (ja) 抗咳剤としてのエンドエテノ／エンドエタノ―エポキシモルヒナン誘導体の（＋）―アイソマー
JPH06500099A (ja) Ｃｎｓ疾病の処置におけるヘテロ環状アミノ―アルコール化合物の使用
EP0078845B1 (en) Anti-convulsant
DE69530205T2 (de) Heterocyclisch kondensierte morphinoid-derivate
EP0007258A1 (fr) Dérivés de l'indole et leur utilisation comme anxiolytiques
KR102269493B1 (ko) (r)-디미라세탐 (1) 및 (s)-디미라세탐 (2)을 비-라세미 비로 포함하는 상승작용적 조성물
SK283711B6 (sk) Liečivo na liečenie úzkosti a panického strachu
JPS58208255A (ja) アミノアルカジエン誘導体
PT612314E (pt) Derivados de etilamina 2-heterociclicos e seu uso como produtos farmaceuticos
Miller et al. Anticonvulsants. IV. An Investigation of α-(Substituted phenyl)-succinimides
US5098925A (en) Spiro-dihydroisoindole compounds
EP0550444A1 (en) Substituted naphthoxazines useful as dopaminergics
CA1167469A (en) N - substituted-benzyl-11-endo-amino-5,6,7,8,9,10- hexahydro-2-hydroxy (or methoxy)-6,9- methanobenzocyclooctene (or nonene) centrally-acting analgesics
RU97112318A (ru) Способ определения лимфотоксичности лекарственных препаратов в реакции спонтанного e-розеткообразования
CN1099386A (zh) 1，2，5，6-四氢吡啶衍生物，其制备方法和它的治疗用途